Tilray Stock Is Not Very Different Since Its Altria Merger

InvestorPlace2021-05-20

TLRY stock may pop one day, but that's what we already knew Now that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（32）

Reindeerrr
·2021-05-20
Pls like and comment thanks!
Reply
Like
Report
ElunMask
·2021-05-20
Cool
Reply
1
Report
Janicetxy
·2021-05-20
Pls help to comment thanks
Reply
3
Report
Fold Replies
- ElunMask:
  Cool
  2021-05-20
  Reply
  Report
schsch
·2021-05-20
comment pls
Reply
2
Report
Fold Replies
- sleepymoon:
  Comment
  2021-05-20
  Reply
  Report
- 我来啦你不要跑:
  Comment
  2021-05-20
  Reply
  Report
4XKEYQ
·2021-05-20
Wow
Reply
Like
Report
Ma_Yi_Long
·2021-05-20
pls like and response
Reply
3
Report
Fold Replies
- 4XKEYQ:
  Pls cmt back
  2021-05-20
  Reply
  Report
Janicetxy
·2021-05-20
??
Reply
3
Report
schsch
·2021-05-20
like and comment pls
Reply
4
Report
Fold Replies
- Ma_Yi_Long:
  ftw
  2021-05-20
  Reply
  Report
- Starbless:
  For the coins
  2021-05-20
  Reply
  Report
wywy
·2021-05-20
pls response n comment
Reply
3
Report
Fold Replies
- Starbless:
  Ok
  2021-05-20
  Reply
  Report
Nathanjo
·2021-05-20
Like and share
Reply
3
Report
Nemea
·2021-05-20
Help like and comment thanks
Reply
3
Report
Fold Replies
- Nathanjo:
  Wah
  2021-05-20
  Reply
  Report
Joshualoh
·2021-05-20
Pls like and comment. Thank you.
Reply
6
Report
Fold Replies
- Joshualoh:
  There u go
  2021-05-20
  Reply
  Report
- Jovvvvv:
  Commented
  2021-05-20
  Reply
  Report
yraymond
·2021-05-20
Like & comment plz
Reply
2
Report
Fold Replies
- Joshualoh:
  There u go Thanks Pls reply back
  2021-05-20
  Reply
  Report
- JoshualohReplying toHuathk:
  Thank you
  2021-05-20
  Reply
  Report
- Huathk:
  K
  2021-05-20
  Reply
  Report
SureWinTun
·2021-05-20
Yes, make sense.
Reply
2
Report
SureWinTun
·2021-05-20
Agreed
Reply
2
Report
Fold Replies
- ccwee:
  liked
  2021-05-20
  Reply
  Report
Xinyong
·2021-05-20
Comment pls
Reply
3
Report
Fold Replies
- Joshualoh:
  There u go Pls reply back Thanks
  2021-05-20
  Reply
  Report
cHao7
·2021-05-20
Like and comment plz
Reply
4
Report
Fold Replies
- cHao7:
  thanks
  2021-05-20
  Reply
  Report
- Xinyong:
  Reply pls
  2021-05-20
  Reply
  Report
missychatty
·2021-05-20
Like and comment pls
Reply
2
Report
Fold Replies
- missychatty:
  Ok
  2021-05-20
  Reply
  Report
- Huathk:
  K
  2021-05-20
  Reply
  Report
- cHao7:
  comment b plz
  2021-05-20
  Reply
  Report
Coo24
·2021-05-20
Ok comment back thanks.
Reply
2
Report
Fold Replies
- cHao7:
  comment b plz
  2021-05-20
  Reply
  Report
- Xinyong:
  Reply pls
  2021-05-20
  Reply
  Report
BigMac8885
·2021-05-20
Pls like and comment :)
Reply
5
Report
Fold Replies
- Coo24:
  Ok
  2021-05-20
  Reply
  Report
- Jazling:
  Respond Pls
  2021-05-20
  Reply
  Report
- BigMac8885:
  ThaNks
  2021-05-20
  Reply
  Report
View more 2 comments

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1160383085?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-20 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160383085","market":"us","top_or_hot":-1,"title":"Tilray Stock Is Not Very Different Since Its Altria Merger","media":"InvestorPlace","content":"<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","article_id":"1160383085","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","pubTimestamp":1621504808,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"Tilray的股票在奥驰亚合并后并没有很大的不同","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":0.9},"content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":130393002,"gmtCreate":1621509945906,"gmtModify":1704358788523,"author":{"id":"3577268548812626","authorId":"3577268548812626","name":"Reindeerrr","avatar":"https://static.tigerbbs.com/4de7d68397230618b1e78d4d7948834e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3577268548812626","idStr":"3577268548812626"},"htmlText":"Pls like and comment thanks!","listText":"Pls like and comment thanks!","text":"Pls like and comment thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130393002","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130390371,"gmtCreate":1621509821593,"gmtModify":1704358786227,"author":{"id":"3579673345882908","authorId":"3579673345882908","name":"ElunMask","avatar":"https://static.tigerbbs.com/4561a4b19c908bdc775c4daf68fb2fc6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579673345882908","idStr":"3579673345882908"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130390371","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130974986,"gmtCreate":1621509006345,"gmtModify":1704358769174,"author":{"id":"3567160842587234","authorId":"3567160842587234","name":"Janicetxy","avatar":"https://static.tigerbbs.com/63b856bdd08debeda5ded66d11e6ed08","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3567160842587234","idStr":"3567160842587234"},"htmlText":"Pls help to comment thanks","listText":"Pls help to comment thanks","text":"Pls help to comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130974986","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390173,"gmtCreate":1621509817560,"gmtModify":1680789909743,"authorId":3579673345882908,"author":{"id":3579673345882908,"idStr":"3579673345882908","authorId":3579673345882908,"name":"ElunMask","avatar":"https://static.tigerbbs.com/4561a4b19c908bdc775c4daf68fb2fc6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130974986,"type":1,"supId":0,"prevId":0,"content":"<u>Cool</u>","text":"<u>Cool</u>","html":"<u>Cool</u>"}],"langContent":"EN"},{"id":130972913,"gmtCreate":1621508883032,"gmtModify":1704358766717,"author":{"id":"3575927670533252","authorId":"3575927670533252","name":"schsch","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575927670533252","idStr":"3575927670533252"},"htmlText":"comment pls","listText":"comment pls","text":"comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/130972913","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390070,"gmtCreate":1621508962044,"gmtModify":1680789912994,"authorId":3555884467896100,"author":{"id":3555884467896100,"idStr":"3555884467896100","authorId":3555884467896100,"name":"sleepymoon","avatar":"https://static.tigerbbs.com/017d47c34167b5c3d7accfb69274dd36","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130972913,"type":1,"supId":4390068,"prevId":0,"content":"Comment","text":"Comment","html":"Comment"},{"id":4390068,"gmtCreate":1621508947464,"gmtModify":1680789911766,"authorId":3546953115990917,"author":{"id":3546953115990917,"idStr":"3546953115990917","authorId":3546953115990917,"name":"我来啦你不要跑","avatar":"https://static.tigerbbs.com/5bd412726b1348c9275f5dcd38fff8a8","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.20","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130972913,"type":1,"supId":0,"prevId":0,"content":"<u>Comment</u>","text":"<u>Comment</u>","html":"<u>Comment</u>"}],"langContent":"EN"},{"id":130976108,"gmtCreate":1621508846504,"gmtModify":1704358765241,"author":{"id":"3575807346407979","authorId":"3575807346407979","name":"4XKEYQ","avatar":"https://static.tigerbbs.com/de3f10a9c3304a65bad52cfc9b4792f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575807346407979","idStr":"3575807346407979"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130976108","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130978102,"gmtCreate":1621508809306,"gmtModify":1704358763756,"author":{"id":"3557722898030015","authorId":"3557722898030015","name":"Ma_Yi_Long","avatar":"https://static.tigerbbs.com/87e91b153216a6f84a5a4ac58894a42e","vip":1,"crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3557722898030015","idStr":"3557722898030015"},"htmlText":"pls like and response","listText":"pls like and response","text":"pls like and response","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130978102","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390055,"gmtCreate":1621508859167,"gmtModify":1680789915087,"authorId":3575807346407979,"author":{"id":3575807346407979,"idStr":"3575807346407979","authorId":3575807346407979,"name":"4XKEYQ","avatar":"https://static.tigerbbs.com/de3f10a9c3304a65bad52cfc9b4792f0","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130978102,"type":1,"supId":0,"prevId":0,"content":"Pls cmt back","text":"Pls cmt back","html":"Pls cmt back"}],"langContent":"EN"},{"id":130978006,"gmtCreate":1621508788405,"gmtModify":1704358763430,"author":{"id":"3567160842587234","authorId":"3567160842587234","name":"Janicetxy","avatar":"https://static.tigerbbs.com/63b856bdd08debeda5ded66d11e6ed08","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3567160842587234","idStr":"3567160842587234"},"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130978006","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130971281,"gmtCreate":1621508763043,"gmtModify":1704358762935,"author":{"id":"3575927670533252","authorId":"3575927670533252","name":"schsch","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575927670533252","idStr":"3575927670533252"},"htmlText":"like and comment pls","listText":"like and comment pls","text":"like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/130971281","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390045,"gmtCreate":1621508785477,"gmtModify":1680789914783,"authorId":3557722898030015,"author":{"id":3557722898030015,"idStr":"3557722898030015","authorId":3557722898030015,"name":"Ma_Yi_Long","avatar":"https://static.tigerbbs.com/87e91b153216a6f84a5a4ac58894a42e","vip":1,"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130971281,"type":1,"supId":0,"prevId":0,"content":"ftw","text":"ftw","html":"ftw"},{"id":4390041,"gmtCreate":1621508776441,"gmtModify":1680789907462,"authorId":3579823532781270,"author":{"id":3579823532781270,"idStr":"3579823532781270","authorId":3579823532781270,"name":"Starbless","avatar":"https://static.tigerbbs.com/2b24864d2bf404491b55d2a9f4f23d92","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130971281,"type":1,"supId":0,"prevId":0,"content":"For the coins","text":"For the coins","html":"For the coins"}],"langContent":"EN"},{"id":130971072,"gmtCreate":1621508719396,"gmtModify":1704358761950,"author":{"id":"3566982670449095","authorId":"3566982670449095","name":"wywy","avatar":"https://static.tigerbbs.com/76ed86374fc7b16c12094c45ea30787c","vip":2,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3566982670449095","idStr":"3566982670449095"},"htmlText":"pls response n comment","listText":"pls response n comment","text":"pls response n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130971072","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390044,"gmtCreate":1621508784294,"gmtModify":1680789913282,"authorId":3579823532781270,"author":{"id":3579823532781270,"idStr":"3579823532781270","authorId":3579823532781270,"name":"Starbless","avatar":"https://static.tigerbbs.com/2b24864d2bf404491b55d2a9f4f23d92","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130971072,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"EN"},{"id":130970245,"gmtCreate":1621508557587,"gmtModify":1704358757832,"author":{"id":"3583751753217510","authorId":"3583751753217510","name":"Nathanjo","avatar":"https://static.tigerbbs.com/1d0981f112a693b651ba690f0042f784","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583751753217510","idStr":"3583751753217510"},"htmlText":"Like and share","listText":"Like and share","text":"Like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130970245","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130947092,"gmtCreate":1621508456616,"gmtModify":1704358756204,"author":{"id":"3569066855191623","authorId":"3569066855191623","name":"Nemea","avatar":"https://static.tigerbbs.com/480149424b6ae5ed798f2863caaa2bfd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3569066855191623","idStr":"3569066855191623"},"htmlText":"Help like and comment thanks&nbsp;","listText":"Help like and comment thanks&nbsp;","text":"Help like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130947092","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389988,"gmtCreate":1621508570447,"gmtModify":1680789914254,"authorId":3583751753217510,"author":{"id":3583751753217510,"idStr":"3583751753217510","authorId":3583751753217510,"name":"Nathanjo","avatar":"https://static.tigerbbs.com/1d0981f112a693b651ba690f0042f784","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.07","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130947092,"type":1,"supId":0,"prevId":0,"content":"Wah","text":"Wah","html":"Wah"}],"langContent":"EN"},{"id":130945235,"gmtCreate":1621508370927,"gmtModify":1704358754084,"author":{"id":"3581542385429790","authorId":"3581542385429790","name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581542385429790","idStr":"3581542385429790"},"htmlText":"Pls like and comment. Thank you.&nbsp;","listText":"Pls like and comment. Thank you.&nbsp;","text":"Pls like and comment. Thank you.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/130945235","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390027,"gmtCreate":1621508699769,"gmtModify":1680789914448,"authorId":3581542385429790,"author":{"id":3581542385429790,"idStr":"3581542385429790","authorId":3581542385429790,"name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130945235,"type":1,"supId":0,"prevId":0,"content":"There u go","text":"There u go","html":"There u go"},{"id":4389986,"gmtCreate":1621508522256,"gmtModify":1680789913917,"authorId":3575115093974562,"author":{"id":3575115093974562,"idStr":"3575115093974562","authorId":3575115093974562,"name":"Jovvvvv","avatar":"https://static.tigerbbs.com/0ad373080935330fb3711b001e92b5fd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130945235,"type":1,"supId":0,"prevId":0,"content":"Commented","text":"Commented","html":"Commented"}],"langContent":"EN"},{"id":130945601,"gmtCreate":1621508363403,"gmtModify":1704358753922,"author":{"id":"3572433590261303","authorId":"3572433590261303","name":"yraymond","avatar":"https://static.tigerbbs.com/b36c19c4d137110d14914ef84d22775c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3572433590261303","idStr":"3572433590261303"},"htmlText":"Like &amp; comment plz","listText":"Like &amp; comment plz","text":"Like & comment plz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/130945601","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389976,"gmtCreate":1621508452734,"gmtModify":1680789913901,"authorId":3581542385429790,"author":{"id":3581542385429790,"idStr":"3581542385429790","authorId":3581542385429790,"name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130945601,"type":1,"supId":0,"prevId":0,"content":"There u go  Thanks  Pls reply back","text":"There u go  Thanks  Pls reply back","html":"There u go  Thanks  Pls reply back"},{"id":4390022,"gmtCreate":1621508686890,"gmtModify":1680789912274,"authorId":3581542385429790,"author":{"id":3581542385429790,"idStr":"3581542385429790","authorId":3581542385429790,"name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3573472992263411,"repliedAuthor":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":130945601,"type":1,"supId":4389976,"prevId":4390001,"content":"Thank you ","text":"Thank you ","html":"Thank you "},{"id":4390001,"gmtCreate":1621508622383,"gmtModify":1680789909013,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130945601,"type":1,"supId":4389976,"prevId":0,"content":"K","text":"K","html":"K"}],"langContent":"EN"},{"id":130946871,"gmtCreate":1621508082693,"gmtModify":1704358750807,"author":{"id":"3581889013623128","authorId":"3581889013623128","name":"SureWinTun","avatar":"https://static.tigerbbs.com/b887e690361d66167214f283496d05a5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581889013623128","idStr":"3581889013623128"},"htmlText":"Yes, make sense.","listText":"Yes, make sense.","text":"Yes, make sense.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130946871","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130941656,"gmtCreate":1621507864675,"gmtModify":1704358748519,"author":{"id":"3581889013623128","authorId":"3581889013623128","name":"SureWinTun","avatar":"https://static.tigerbbs.com/b887e690361d66167214f283496d05a5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581889013623128","idStr":"3581889013623128"},"htmlText":"Agreed","listText":"Agreed","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130941656","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389908,"gmtCreate":1621507898968,"gmtModify":1680789904934,"authorId":3581829959470650,"author":{"id":3581829959470650,"idStr":"3581829959470650","authorId":3581829959470650,"name":"ccwee","avatar":"https://static.tigerbbs.com/652d99331e3c23c682d7e58cfc9f6544","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.28%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130941656,"type":1,"supId":0,"prevId":0,"content":"liked","text":"liked","html":"liked"}],"langContent":"EN"},{"id":130941939,"gmtCreate":1621507801821,"gmtModify":1704358747541,"author":{"id":"3576057963899009","authorId":"3576057963899009","name":"Xinyong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3576057963899009","idStr":"3576057963899009"},"htmlText":"Comment pls","listText":"Comment pls","text":"Comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130941939","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389968,"gmtCreate":1621508393577,"gmtModify":1680789909885,"authorId":3581542385429790,"author":{"id":3581542385429790,"idStr":"3581542385429790","authorId":3581542385429790,"name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130941939,"type":1,"supId":0,"prevId":0,"content":"There u go  Pls reply back  Thanks","text":"There u go  Pls reply back  Thanks","html":"There u go  Pls reply back  Thanks"}],"langContent":"EN"},{"id":130943827,"gmtCreate":1621507746869,"gmtModify":1704358748031,"author":{"id":"3571630433284403","authorId":"3571630433284403","name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571630433284403","idStr":"3571630433284403"},"htmlText":"Like and comment plz","listText":"Like and comment plz","text":"Like and comment plz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/130943827","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389896,"gmtCreate":1621507828592,"gmtModify":1680789903087,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130943827,"type":1,"supId":4389893,"prevId":0,"content":"<u>thanks</u>","text":"<u>thanks</u>","html":"<u>thanks</u>"},{"id":4389893,"gmtCreate":1621507812334,"gmtModify":1680789901284,"authorId":3576057963899009,"author":{"id":3576057963899009,"idStr":"3576057963899009","authorId":3576057963899009,"name":"Xinyong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130943827,"type":1,"supId":0,"prevId":0,"content":"Reply pls","text":"Reply pls","html":"Reply pls"}],"langContent":"EN"},{"id":130943041,"gmtCreate":1621507714083,"gmtModify":1704358746388,"author":{"id":"3560333139103013","authorId":"3560333139103013","name":"missychatty","avatar":"https://static.tigerbbs.com/d75cdb42cbca99e3666b7b1796540245","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3560333139103013","idStr":"3560333139103013"},"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/130943041","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4390235,"gmtCreate":1621510445553,"gmtModify":1680789914364,"authorId":3560333139103013,"author":{"id":3560333139103013,"idStr":"3560333139103013","authorId":3560333139103013,"name":"missychatty","avatar":"https://static.tigerbbs.com/d75cdb42cbca99e3666b7b1796540245","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130943041,"type":1,"supId":4389886,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4390007,"gmtCreate":1621508639517,"gmtModify":1680789908876,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130943041,"type":1,"supId":4389886,"prevId":0,"content":"K","text":"K","html":"K"},{"id":4389886,"gmtCreate":1621507758442,"gmtModify":1680789900037,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130943041,"type":1,"supId":0,"prevId":0,"content":"comment b <u>plz</u>","text":"comment b <u>plz</u>","html":"comment b <u>plz</u>"}],"langContent":"EN"},{"id":130949845,"gmtCreate":1621507605387,"gmtModify":1704358745398,"author":{"id":"3565954513972782","authorId":"3565954513972782","name":"Coo24","avatar":"https://static.tigerbbs.com/8f9f40c3988dd98ed506a29a2b844507","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3565954513972782","idStr":"3565954513972782"},"htmlText":"Ok comment back thanks.&nbsp;","listText":"Ok comment back thanks.&nbsp;","text":"Ok comment back thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/130949845","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389899,"gmtCreate":1621507835142,"gmtModify":1680789899289,"authorId":3571630433284403,"author":{"id":3571630433284403,"idStr":"3571630433284403","authorId":3571630433284403,"name":"cHao7","avatar":"https://static.tigerbbs.com/3800b5d66328f3184368a219227b02a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130949845,"type":1,"supId":0,"prevId":0,"content":"comment b <u>plz</u>","text":"comment b <u>plz</u>","html":"comment b <u>plz</u>"},{"id":4389895,"gmtCreate":1621507823995,"gmtModify":1680789898966,"authorId":3576057963899009,"author":{"id":3576057963899009,"idStr":"3576057963899009","authorId":3576057963899009,"name":"Xinyong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130949845,"type":1,"supId":0,"prevId":0,"content":"Reply pls","text":"Reply pls","html":"Reply pls"}],"langContent":"EN"},{"id":130957343,"gmtCreate":1621507419982,"gmtModify":1704358742456,"author":{"id":"3579506230138289","authorId":"3579506230138289","name":"BigMac8885","avatar":"https://static.tigerbbs.com/e583c75322dd4651672938ebba8683b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3579506230138289","idStr":"3579506230138289"},"htmlText":"Pls like and comment :)","listText":"Pls like and comment :)","text":"Pls like and comment :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/130957343","repostId":1160383085,"repostType":4,"repost":{"id":"1160383085","pubTimestamp":1621504808,"share":"https://ttm.financial/m/news/1160383085?lang=&edition=fundamental","pubTime":"2021-05-20 18:00","market":"us","language":"en","title":"Tilray Stock Is Not Very Different Since Its Altria Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383085","media":"InvestorPlace","summary":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has pass","content":"<p>TLRY stock may pop one day, but that's what we already knew</p>\n<p>Now that the merger with Aphria has passed, does it make sense to purchase&nbsp;<b>Tilray</b>&nbsp;(NASDAQ:<b><u>TLRY</u></b>) stock? That’s the basic question for which investors are seeking an answer.</p>\n<p>For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.</p>\n<p>Let’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?</p>\n<p><b>Time Will Tell</b></p>\n<p>The old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.</p>\n<p>One figure to look at is Tilray’s projection that&nbsp;within 24 months of the late April merger&nbsp;it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.</p>\n<p>It’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.</p>\n<p>In any case, it’ll be easy to make a quantitative-based judgment call at that time.</p>\n<p>All we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.</p>\n<p><b>Markets Are Hesitant Now</b></p>\n<p>A brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.</p>\n<p>Eleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.</p>\n<p>Investment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.</p>\n<p><b>Tilray’s CPG Strategy</b></p>\n<p>Tilray’s investor presentation for the Aphria merger indicated&nbsp;how the merged company will approach&nbsp;the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.</p>\n<p>Along those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to&nbsp;17,000 North American&nbsp;retail stores which will bring more awareness of Aphria products.</p>\n<p>Tilray also has a joint venture with&nbsp;<b>Anheuser-Busch InBev</b>&nbsp;(NYSE:<b><u>BUD</u></b>), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.</p>\n<p>Tilray’s latest&nbsp;10-Q&nbsp;sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).</p>\n<p>In the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.</p>\n<p><b>The Bottom Line on TLRY Stock</b></p>\n<p>Tilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock Is Not Very Different Since Its Altria Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock Is Not Very Different Since Its Altria Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which ...</p>\n\n<a href=\"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://investorplace.com/2021/05/tilray-stock-not-very-different-since-altria-merger/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160383085","content_text":"TLRY stock may pop one day, but that's what we already knew\nNow that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.\nFor investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG) efforts will bear returns. The company will introduce its brands through craft beers and other beverages to increase awareness. The company also plans to expand its presence in CBD and other cannabinoids.\nLet’s start by tackling how long it will take for the merger to really shake out. When can investors expect to be able to accurately judge whether the deal has provided value?\nTime Will Tell\nThe old maxim serves no utility for investors. But it’s a relevant answer to how long investors should anticipate waiting to understand the true ramifications of the merger.\nOne figure to look at is Tilray’s projection that within 24 months of the late April merger it will achieve 100 million CAD ($82.4 million) in pre-tax cost savings. Therefore, we can reasonably anticipate that the company believes Aphria and Tilray’s disparate operations will be fully integrated by that time.\nIt’s probably more accurate that I say Tilray believes that in 24 months the two will be fully integrated and reflective of post-merger value.\nIn any case, it’ll be easy to make a quantitative-based judgment call at that time.\nAll we’ll have to do then is take a dive into the financials in a year and half from now, and fish out that pre-tax cost savings figure. If it exceeds 100 million CAD, that should indicate that the merger has proven accretive. If not, the opposite should be true. Expect markets to respond in kind whatever happens.\nMarkets Are Hesitant Now\nA brief glance at the price chart of Tilray over the past three years tells a broad narrative about the market and cannabis stocks. Tilray became publicly traded in July 2018. Shares traded for about twice their current value then. Within two months share prices reached $214.\nEleven months later TLRY stock was down to its IPO price. Prices were flat and trending down for the next year and a half. Then, viola! Prices spiked to $64 in February of this year.\nInvestment in Tilray is not for the faint of heart, and that goes for the broader cannabis industry as well. For Tilray to truly thrive its CPG presence in the U.S. will be vital.\nTilray’s CPG Strategy\nTilray’s investor presentation for the Aphria merger indicated how the merged company will approach the U.S. market. The company is relying on two strategic pillars: branded cannabis lifestyle, and a hemp and wellness platform.\nAlong those lines, Tilray acquired Atlanta-based Sweetwater Brewing for $300 million. Tilray is using the beer company’s distribution network to build awareness of its own products. Tilray’s Manitoba Harvest brand has access to 17,000 North American retail stores which will bring more awareness of Aphria products.\nTilray also has a joint venture with Anheuser-Busch InBev (NYSE:BUD), giving its CPG business another base for potential success. The business, called Fluent, has yet to provide much to the company though.\nTilray’s latest 10-Q sheds light on that fact. In the first quarter of 2020, Tilray realized a net loss of $3.496 million from Fluent (and Cannafections – its other JV).\nIn the same period in 2021, the two 50% owned JVs saw a net loss of $3.574 million. Basically, they were stagnant at a high level.\nThe Bottom Line on TLRY Stock\nTilray remains essentially the same as it was prior to the merger: A company with lots of promise, but little to interest investors right now. Therefore, an investment in Tilray is really little more than hope that the cannabis industry finally takes off after all of the hype.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389876,"gmtCreate":1621507631956,"gmtModify":1680789902501,"authorId":3565954513972782,"author":{"id":3565954513972782,"idStr":"3565954513972782","authorId":3565954513972782,"name":"Coo24","avatar":"https://static.tigerbbs.com/8f9f40c3988dd98ed506a29a2b844507","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.14%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130957343,"type":1,"supId":4389867,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4389867,"gmtCreate":1621507551832,"gmtModify":1680789902294,"authorId":3566821013640470,"author":{"id":3566821013640470,"idStr":"3566821013640470","authorId":3566821013640470,"name":"Jazling","avatar":"https://static.tigerbbs.com/85e0a83573d9307f57fca9b2baed72af","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.25","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130957343,"type":1,"supId":0,"prevId":0,"content":"Respond Pls","text":"Respond Pls","html":"Respond Pls"},{"id":4389868,"gmtCreate":1621507559037,"gmtModify":1680789900970,"authorId":3579506230138289,"author":{"id":3579506230138289,"idStr":"3579506230138289","authorId":3579506230138289,"name":"BigMac8885","avatar":"https://static.tigerbbs.com/e583c75322dd4651672938ebba8683b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130957343,"type":1,"supId":4389867,"prevId":0,"content":"ThaNks","text":"ThaNks","html":"ThaNks"},{"id":4389862,"gmtCreate":1621507515244,"gmtModify":1680789899120,"authorId":3568118324159741,"author":{"id":3568118324159741,"idStr":"3568118324159741","authorId":3568118324159741,"name":"JKMH","avatar":"https://static.tigerbbs.com/dddf91fd30e608846e60552493a12c4e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130957343,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"},{"id":4389859,"gmtCreate":1621507507140,"gmtModify":1680789898605,"authorId":3579506230138289,"author":{"id":3579506230138289,"idStr":"3579506230138289","authorId":3579506230138289,"name":"BigMac8885","avatar":"https://static.tigerbbs.com/e583c75322dd4651672938ebba8683b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130957343,"type":1,"supId":4389853,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":43,"commentSize":32,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}